Formulation and evaluation of dexlansoprazole extended-release tablet

Dexlansoprazole (DSP) is a proton pump inhibitor, it used to treat GERD and ulcer colitis. DSP works by decreasing the volume of acid in stomach. an acid-labile medication that may be destroyed stomach's acidic pH. A coating technique was postpone drug release stomach, which can extend pharmacological activity. Shellac develop sustain tablet dexlansoprazole as retardation (dexlansoprazole) observed pH hence coated prepared evaluated. The coating's primary function allow for delayed, immediate, prolonged delayed DSP. with different polymers inhibits faster degradation therefore increasing action. fast pH, enhancing major enable breakdown